James L. Gulley, M.D., Ph.D., F.A.C.P.
Laboratory of Tumor Immunology and Biology
Director, Clinical Immunotherapy Group
Senior Investigator
National Cancer Institute
Building 10, Room 5B52
Bethesda, MD 20892
Phone: 301-435-2956
Fax: 301-480-1779
gulleyj@mail.nih.gov
Dr. Gulley is a board-certified medical oncologist and Director of the Clinical Trials Group within the Laboratory of Tumor Immunology and Biology at the National Cancer Institute (NCI). He is also a Senior Investigator within the Medical Oncology Branch. He received his medical training at Loma Linda University in its medical scientist training program where he obtained a Ph.D. with his work in tumor immunology as well as an M.D. He went to Emory University for a residency in internal medicine and then to NCI for a fellowship in medical oncology. Following his fellowship, he was retained as senior staff within NCI. Dr. Gulley has run multiple clinical trials in immunotherapy since 1999 and is an internationally recognized expert in this field.
Dr. Gulley's Clinical Trial(s):
NCI’s Center for Cancer Research (CCR) is currently conducting the following trial(s) for patients with breast cancer, prostate cancer, or solid tumors. Click on the trial(s) below for additional details, including a summary of key eligibility criteria, study outline, and information on how to contact the study team directly.
Back to Top
